Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 3/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 6/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18172504 | 0.91 | TSHR (0.44) | P2RY14NOTUMKMT2ATP53NPC1 | |
| SCHEMBL18172387 | 0.91 | P2RY14 (0.41) | P2RY14KMT2ATP53NPC1RAB9A | |
| SCHEMBL18172408 | 0.86 | P2RY14 (0.47) | P2RY14CCR1F2NOTUMMEN1 | |
| SCHEMBL18172429 | 0.83 | P2RX3 (0.39) | P2RY14CCR1NOTUMMEN1KMT2A | |
| SCHEMBL18172406 | 0.83 | CCR1 (0.46) | P2RY14CCR1F2NOTUMMEN1 | |
| SCHEMBL20533434 | 0.83 | P2RY14 (0.44) | P2RY14CCR1F2NOTUMMEN1 | |
| SCHEMBL18172462 | 0.83 | CCR1 (0.46) | P2RY14CCR1F2NOTUMMEN1 | |
| SCHEMBL18172404 | 0.83 | P2RX3 (0.37) | P2RY14CCR1 | |
| SCHEMBL18172496 | 0.82 | P2RX3 (0.38) | P2RY14KMT2ATP53 | |
| SCHEMBL18172417 | 0.80 | PRCP (0.38) | P2RY14CCR1TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3286182-A1 | TETRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | F. Hoffmann-La Roche AG (CH) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016169902-A1 | TETRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2016-10-27 | — | — | WO | disclosed |